Atripla Is More Than Just the Sum of Its Three PartsNew study: People with HIV who take the once-a-day combination pill of tenofovir+emtricitabine+efavirenz are less likely to develop drug resistance and take longer to reach virologic failure (if it occurs) than those who take an equivalent combo of 3 separate pills.
These findings underline the potential risks of prescribing Atripla’s individual components separately to save money, which experts say could happen as the ARVs lose their patents and generics enter the market.

Atripla Is More Than Just the Sum of Its Three Parts

New study: People with HIV who take the once-a-day combination pill of tenofovir+emtricitabine+efavirenz are less likely to develop drug resistance and take longer to reach virologic failure (if it occurs) than those who take an equivalent combo of 3 separate pills.

These findings underline the potential risks of prescribing Atripla’s individual components separately to save money, which experts say could happen as the ARVs lose their patents and generics enter the market.

Fighting HIV in the Ivory Coast: WHOs New Guidelines Benefit FewSo, the World Health Organization is advising that all people with HIV in the Ivory Coast take ARVs if they have an HIV-negative partner. That sounds good right? Well, considering the shaky disclosure practices between couples in the country, these new TaSP guidelines mean only 12% of the population will ultimately qualify…

Fighting HIV in the Ivory Coast: WHOs New Guidelines Benefit Few

So, the World Health Organization is advising that all people with HIV in the Ivory Coast take ARVs if they have an HIV-negative partner. That sounds good right? Well, considering the shaky disclosure practices between couples in the country, these new TaSP guidelines mean only 12% of the population will ultimately qualify…

Providing TaSP When Stuck Between a Rock & a Hard Place

In the absence of universal antiretroviral (ARV) treatment, should we prioritize on providing HIV meds to the main drivers of the epidemic first before making them available to the rest of the population? This new theory from aidsmap says yes.

If countries followed the idea, it would mean injection drug users and female sex workers would be treated before all other at-risk groups.

Q: What is the HIV treatment cascade?
A: The treatment cascade is a descending, or “cascading” bar graph that begins with a bar representing the number of all HIV+ people and basically falls with each progressive bar, which account for those who have then been: diagnosed; linked to medical care; retained in care; prescribed ARVs; and have achieved a suppressed viral load.
Why do we use it? Several studies show that it’s easy for people to fall through the cracks at each step along the way, presenting unique challenges to defeating the virus in especially at-risk communities.

Q: What is the HIV treatment cascade?

A: The treatment cascade is a descending, or “cascading” bar graph that begins with a bar representing the number of all HIV+ people and basically falls with each progressive bar, which account for those who have then been: diagnosed; linked to medical care; retained in care; prescribed ARVs; and have achieved a suppressed viral load.

Why do we use it? Several studies show that it’s easy for people to fall through the cracks at each step along the way, presenting unique challenges to defeating the virus in especially at-risk communities.